Kirsten Leute and Margalit Haber at Osage University Partners (OUP) will provide an in-depth look at venture capital perspectives on the economics of university startup formation.

Meet Dr. Julia Miller, Ph.D. ‘20. Julia is a recent Cornell graduate who completed her Ph.D. in Plant Biology from the School of Integrative Plant Science. Julia learned about opportunities in technology transfer while attending talks on ‘alternative’ careers for Ph.D. students. During her time at Cornell, Julia was a CTL Practicum member

On March 12, 2021, CTL hosted the first installation of the Weill Digital Health Series: Digital Health Innovations – What They Are, How to Protect Them, and Commercialization Strategies

Watch the third WI2 webinar, where Rachel Dorin, Ph.D., President and CEO, and Co-Founder, Terapore and Siyu Huang, Ph.D., Co-Founder and CEO, Lionanowe speak with Alice Li, Ph.D., Executive Director, Center for Technology Licensing, Cornell University about their experience as female founders/CEOs.

The Innovation Fellows program offers prospective candidates the opportunity to work full-time for up to three years in technology licensing, startups, business development, and IP protection.

Applications are now being accepted for IGNITE:Startup Project and are welcome on a rolling basis.

Join us Thurs, April 22nd, at 12 noon for the CTL IP Series 3: #Software, #Copyright, and #Trademark

During this virtual meeting, the team at CTL will provide information about the objectives of the program, the requirements to apply, and the selection process.

In this second session, our guest experts will present an overview of the regulatory landscape and the challenges related to privacy and data protection.

Join us for a panel discussion on the impacts of COVID-19 on the fruit and vegetable markets across the U.S.A. and specifically in New York State.

For the third WI2 webinar, we speak with two women founders and CEOs from Cornell University to find out about their experience as female founders/CEOs and to hear about the lessons learned during the formation and the growth of their venture.

After Margaret Bynoe and her lab discovered that an FDA-approved drug, Lexiscan, used in cardiac imaging, could open the blood-brain barrier, the lab went to work, exploring how it could be used as a therapeutic for brain diseases.

Lynden Archer is searching for ways to give fossil fuels a different life. His lab has already discovered some invaluable new processes and products.

A wrist device lowers heart rate; a bedside device monitors sleep quality; a dinner plate controls food quantity. Tanzeem Choudhury makes it happen.

Ilana L. Brito and her team are developing a suite of computational tools for examining the mobile gene content in multiple datasets — to identify those genes that may shape the response of microbial communities to stress.

Emin Gün Sirer’s research group developed and tested Falcon — which they call fast and fierce — for processing Bitcoin blockchains, digital transaction ledgers.

When bacteria live in a community known as biofilm, antibiotics can’t enter to fight infection. Holger Sondermann wants to disperse that community.

As a pioneer of single-molecule imaging, Peng Chen applies the technology to studying metal atoms in cells, with implications for the development of antibacterial agents.

Dr. Hening Lin is an Investigator in the Howard Hughes Medical Center and Professor of Chemistry and Chemical Biology at Cornell University. Dr. Lin’s understanding of sirtuin enzymatic activity has enabled the development of a potent sirtuin2-specific inhibitor called “TM.”

Dr. Benedict Law is an Assistant Professor of Pharmacology in Radiology at Weill Cornell Medicine. Dr. Law’s team is interested in a new type of two-dimensional nanomaterial, such as nanofiber (PF) that is biocompatible, able to penetrate inside a tumor, and has a short circulation time to avoid non-specific in vivo distribution with a high tumor uptake.

Dr. Robert Shepherd, Assistant Professor of Mechanical and Aerospace Engineering, and his team have developed foam actuators and sensors to create soft robotics that are safe for use in prosthetics and enhance augmented and virtual reality experiences.

Paul Steen, Professor in Chemical and Biomolecular Engineering, has developed a switchable electronically- controlled adhesion device that allows for maximum adhesion to various surfaces. Among the applications for the device are wafer handling, large-format printing, gripping gloves and shoes, and drone parking pods.